Description
Book SynopsisChlamydia pneumoniae is now recognized as an important human pathogen. Chlamydia pneumoniae is involved in 5%-15% of community acquired pneumonias, and recent data indicate its relevance in severe pneumonia and as a respiratory pathogen in immunocompromised subjects. A causal role for Chlamydia pneumoniae in the initiation, exacerbations and promotion of asthma has been suggested. Approximately 5% of chronic bronchitis exacerbations have been attributed to Chlamydia pneumoniae infections, and chronic infection may facilitate access of other pathogens to the lower respiratory tract. Another field of potential great social impact is the possible involvement of Chlamydia pneumoniae in the pathogenesis of atherosclerosis and related cardiovascular diseases. This book presents the current state-of-the-art knowledge on Chlamydia pneumoniae infection and highlights future lines of research.
Table of ContentsHistory of Chlamydia Pneumoniae (TWAR) Chlamydia Pneumoniae Microbiology Chlamydia Pneumoniae: Culture Methods Serology for Chlamydia Pneumoniae (TWAR) Chlamydia Pneumoniae: Molecular Biology Methods Chlamydia Pneumoniae Infections: Application of Laboratory Methods Chlamydia Pneumoniae: How to Document Respiratory Infection Chlamydia Pneumoniae: Epidemiology, Pharmacological and Pharmacokinetic Basis of Chlamydia Pneumoniae Treatment Chlamydia Pneumoniae: Clinical Characteristics of Acute Respiratory Infections Are Atypical Pathogens Important for Patients with Communicty Acquired Pneumoniae Immunology of Chlamydia Pneumoniae Chronic Chlamydia Pneumoniae Infections Chlamydia Pneumoniae, a new possible cause of Asthma Chlamydia Pneumoniae: Evidence for a Role in Children Infections Chlamydia Pneumoniae: An Important Pathogen in Chronic Bronchitis Chlamydia Pneumoniae: A New Threat for HIV-Infected Subjects Chlamydia Pneumoniae: Epidemiology of a New Cardiovascular Risk Factor Chlamyida Pneumoniae and Atherosclerosis: Mechanisms of Vacular Damage Chlamydia Pneumoniae and Atherosclerosis: Animal Models Open and Controlled Interventions Trials for 'Unusual' anti Chlamydia Pneumoniae Indications: Asthma, Atherosclerosis, Myocardial Infarction Perspectives and Perceptions on the Clinical Relevance of Chlamydia Pneumoniae Infections.
